Why the FDA Isn't Thrilled About Moderna's COVID-19 Booster
On Wednesday, the Food and Drug Administration granted Emergency Use Authorization for boosters of Moderna's (NASDAQ: MRNA) COVID-19 vaccine. This decision came despite the fact that briefing documents prepared by the FDA for an advisory committee's review of Moderna's booster data weren't overly enthusiastic. In this Motley Fool Live video recorded on Oct. 13, Motley Fool contributors Keith Speights and Brian Orelli discuss why the FDA isn't thrilled about Moderna's COVID-19 boosters.
Source Fool.com
